SINGAPORE, May 10, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company focused on the discovery and development of new breakthrough therapies, has closed an extended Series B funding round of US$25 million. This brings the total capital raised through...
from PR Newswire: https://ift.tt/2WJmZTp
No comments:
Post a Comment